Vaccination in the Era of Precision Medicine: Tailoring Immunization Strategies for Individual Risk Profiles

Year : 2024 | Volume :01 | Issue : 02 | Page : 32-47
By

    Shruti Morankar

  1. Samruddhi Waghchaure

Abstract

The introduction of precision medicine has caused a paradigm change in the vaccine landscape. Conventionally, vaccination programmes have been homogeneous, targeting immunity at the population level without taking into consideration the individual differences in immune response and vulnerability to diseases that can be prevented by vaccination. However, a more individualised approach to immunisation has been made possible by current developments in genetics, immunology, and data analytics. Within the context of precision medicine, the idea of adjusting vaccination regimens to each patient’s unique risk profile is examined in this article. The implementation of precision vaccination has several hurdles, including ethical considerations, privacy concerns, and the requirement for a strong infrastructure to facilitate data integration and analysis. Inequalities in vaccine uptake and effectiveness may also be made worse by differences in access to healthcare and genetic testing. Collaboration amongst various stakeholders, such as healthcare professionals, researchers, policymakers, and technology developers, is necessary to tackle these difficulties. the era of precision medicine presents previously unheard-of chances to completely transform immunisation programmes. We may advance towards a future where vaccinations are not only effective at the population level but also customised to meet the specific needs of each individual, maximising the impact of vaccination efforts on public health, by adopting a personalised approach to immunisation

Keywords: Vaccination, precision medicine, immunisation, paradigm, genetics, homogeneous.

[This article belongs to International Journal of Vaccines(ijv)]

How to cite this article: Shruti Morankar, Samruddhi Waghchaure.Vaccination in the Era of Precision Medicine: Tailoring Immunization Strategies for Individual Risk Profiles.International Journal of Vaccines.2024; 01(02):32-47.
How to cite this URL: Shruti Morankar, Samruddhi Waghchaure , Vaccination in the Era of Precision Medicine: Tailoring Immunization Strategies for Individual Risk Profiles ijv 2024 {cited 2024 Mar 30};01:32-47. Available from: https://journals.stmjournals.com/ijv/article=2024/view=136866


References

  1. Ashley, E.A., 2016. Towards precision medicine. Nature Reviews Genetics, 17(9), pp.507-522.
  2. Kosorok, M.R. and Laber, E.B., 2019. Precision medicine. Annual review of statistics and its application, 6, pp.263-286.
  3. König, I.R., Fuchs, O., Hansen, G., von Mutius, E. and Kopp, M.V., 2017. What is precision medicine?. European respiratory journal, 50(4).
  4. Ginsburg, G.S. and Phillips, K.A., 2018. Precision medicine: from science to value. Health affairs, 37(5), pp.694-701.
  5. Collins, F.S. and Varmus, H., 2015. A new initiative on precision medicine. New England journal of medicine, 372(9), pp.793-795.
  6. Mirnezami, R., Nicholson, J. and Darzi, A., 2012. Preparing for precision medicine. N Engl J Med, 366(6), pp.489-491.
  7. Duffy, D.J., 2016. Problems, challenges and promises: perspectives on precision medicine. Briefings in bioinformatics, 17(3), pp.494-504.
  8. Bahcall, O., 2015. Precision medicine. Nature, 526(7573), p.335.
  9. Dugger, S.A., Platt, A. and Goldstein, D.B., 2018. Drug development in the era of precision medicine. Nature reviews Drug discovery, 17(3), pp.183-196.
  10. Aronson, S.J. and Rehm, H.L., 2015. Building the foundation for genomics in precision medicine. Nature, 526(7573), pp.336-342.
  11. Nakagawa, H. and Fujita, M., 2018. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer science, 109(3), pp.513-522.
  12. Zeggini, E., Gloyn, A.L., Barton, A.C. and Wain, L.V., 2019. Translational genomics and precision medicine: Moving from the lab to the clinic. Science, 365(6460), pp.1409-1413.
  13. Williams, A.M., Liu, Y., Regner, K.R., Jotterand, F., Liu, P. and Liang, M., 2018. Artificial intelligence, physiological genomics, and precision medicine. Physiological genomics, 50(4), pp.237-243.
  14. Xu, J., Yang, P., Xue, S., Sharma, B., Sanchez-Martin, M., Wang, F., Beaty, K.A., Dehan, E. and Parikh, B., 2019. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Human genetics, 138(2), pp.109-124.
  15. Pena, S.D. and Tarazona-Santos, E., 2022. Clinical genomics and precision medicine. Genetics and molecular biology, 45, p.e20220150.
  16. Cardon, L.R. and Harris, T., 2016. Precision medicine, genomics and drug discovery. Human molecular genetics, 25(R2), pp.R166-R172.
  17. Dominiczak, A., Delles, C. and Padmanabhan, S., 2017. Genomics and precision medicine for clinicians and scientists in hypertension. Hypertension, 69(4), pp.e10-e13.
  18. Doherty, T.M., Di Pasquale, A., Michel, J.P. and Del Giudice, G., 2020. Precision medicine and vaccination of older adults: from reactive to proactive (a mini-review). Gerontology, 66(3), pp.238-248.
  19. Duraisamy, G.S., Bhosale, D., Lipenská, I., Huvarova, I., Růžek, D., Windisch, M.P. and Miller, A.D., 2020. Advanced therapeutics, vaccinations, and precision medicine in the treatment and management of chronic hepatitis b viral infections; where are we and where are we going?. Viruses, 12(9), p.998.
  20. Omersel, J. and Karas Kuželički, N., 2020. Vaccinomics and adversomics in the era of precision medicine: a review based on HBV, MMR, HPV, and COVID-19 vaccines. Journal of clinical medicine, 9(11), p.3561.
  21. Postigo-Fernandez, J., Firdessa-Fite, R. and Creusot, R.J., 2022. Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes. Proceedings of the National Academy of Sciences, 119(15), p.e2110987119.
  22. Postigo-Fernandez, J., Firdessa-Fite, R. and Creusot, R.J., 2022. Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes. Proceedings of the National Academy of Sciences, 119(15), p.e2110987119.
  23. Ke, C.H., Chiu, Y.H., Huang, K.C. and Lin, C.S., 2022. Exposure of immunogenic tumor antigens in surrendered immunity and the significance of autologous tumor cell-based vaccination in precision medicine. International Journal of Molecular Sciences, 24(1), p.147.
  24. Kensler, T.W., Spira, A., Garber, J.E., Szabo, E., Lee, J.J., Dong, Z., Dannenberg, A.J., Hait, W.N., Blackburn, E., Davidson, N.E. and Foti, M., 2016. Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prevention Research, 9(1), pp.2-10.
  25. Jia, S., Li, J., Liu, Y. and Zhu, F., 2020. Precision immunization: a new trend in human vaccination. Human Vaccines & Immunotherapeutics, 16(3), pp.513-522.
  26. Angelidou, A., Evans, J., Idoko, O., Levy, O., Lewis, N.P., Nanishi, E., Odumade, O.A., Ozonoff, A., Plotkin, S., Sherman, A.C. and van Haren, S.D., 2022. Precision vaccines: Lessons learned from the coronavirus pandemic. Clinical Infectious Diseases, 75(Supplement_1), pp.S1-S1.
  27. Vannini, A., Parenti, F., Bressanin, D., Barboni, C., Zaghini, A., Campadelli-Fiume, G. and Gianni, T., 2021. Towards a precision medicine approach and in situ vaccination against prostate cancer by PSMA-retargeted oHSV. Viruses, 13(10), p.2085.
  28. Seymour, C.W., Gomez, H., Chang, C.C.H., Clermont, G., Kellum, J.A., Kennedy, J., Yende, S. and Angus, D.C., 2017. Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. Critical Care, 21, pp.1-11.
  29. Khoury, M.J., Gwinn, M.L., Glasgow, R.E. and Kramer, B.S., 2012. A population approach to precision medicine. American journal of preventive medicine, 42(6), pp.639-645.
  30. König, I.R., Fuchs, O., Hansen, G., von Mutius, E. and Kopp, M.V., 2017. What is precision medicine?. European respiratory journal, 50(4).
  31. Duffy, D.J., 2016. Problems, challenges and promises: perspectives on precision medicine. Briefings in bioinformatics, 17(3), pp.494-504.
  32. MacEachern, S.J. and Forkert, N.D., 2021. Machine learning for precision medicine. Genome, 64(4), pp.416-425.
  33. Ashley, E.A., 2016. Towards precision medicine. Nature Reviews Genetics, 17(9), pp.507-522.
  34. Denson, L.A., Curran, M., McGovern, D.P., Koltun, W.A., Duerr, R.H., Kim, S.C., Sartor, R.B., Sylvester, F.A., Abraham, C., de Zoeten, E.F. and Siegel, C.A., 2019. Challenges in IBD research: precision medicine. Inflammatory bowel diseases, 25(Supplement_2), pp.S31-S39.
  35. Friedenreich, C.M., Neilson, H.K., Farris, M.S. and Courneya, K.S., 2016. Physical activity and cancer outcomes: a precision medicine approach. Clinical Cancer Research, 22(19), pp.4766-4775.
  36. Hulsen, T., Jamuar, S.S., Moody, A.R., Karnes, J.H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D.A. and McKinney, E.F., 2019. From big data to precision medicine. Frontiers in medicine, 6, p.34.
  37. Carini, C., Fidock, M. and van Gool, A. eds., 2019. Handbook of biomarkers and precision medicine. Taylor & Francis.
  38. Collins, D.C., Sundar, R., Lim, J.S. and Yap, T.A., 2017. Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics. Trends in pharmacological sciences, 38(1), pp.25-40.
  39. Boyapati, R.K., Kalla, R., Satsangi, J. and Ho, G.T., 2016. Biomarkers in search of precision medicine in IBD. Official journal of the American College of Gastroenterology| ACG, 111(12), pp.1682-1690.
  40. Wermuth, P.J., Piera-Velazquez, S., Rosenbloom, J. and Jimenez, S.A., 2018. Existing and novel biomarkers for precision medicine in systemic sclerosis. Nature Reviews Rheumatology, 14(7), pp.421-432.
  41. Le-Niculescu, H., Roseberry, K., Levey, D.F., Rogers, J., Kosary, K., Prabha, S., Jones, T., Judd, S., McCormick, M.A., Wessel, A.R. and Williams, A., 2020. Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs. Molecular psychiatry, 25(5), pp.918-938.
  42. Beger, R.D., Schmidt, M.A. and Kaddurah-Daouk, R., 2020. Current concepts in pharmacometabolomics, biomarker discovery, and precision medicine. Metabolites, 10(4), p.129.
  43. Gualandro, D.M., Twerenbold, R., Boeddinghaus, J., Nestelberger, T., Puelacher, C. and Mueller, C., 2019. Biomarkers in cardiovascular medicine: towards precision medicine. Swiss medical weekly, 149(4142), pp.w20125-w20125.
  44. Sweeney, T., Quispe, R., Das, T., Juraschek, S.P., Martin, S.S. and Michos, E.D., 2021. The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review. Expert review of precision medicine and drug development, 6(4), pp.247-258.
  45. Shibata, M. and Hoque, M.O., 2018. Development of biomarkers for real precision medicine. Translational Lung Cancer Research, 7(Suppl 3), p.S228.
  46. Olivier, M., Asmis, R., Hawkins, G.A., Howard, T.D. and Cox, L.A., 2019. The need for multi-omics biomarker signatures in precision medicine. International journal of molecular sciences, 20(19), p.4781.
  47. Qoronfleh, M.W., Chouchane, L., Mifsud, B., Al Emadi, M. and Ismail, S., 2020. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar. Life sciences, society and policy, 16, pp.1-20.
  48. Seyhan, A.A. and Carini, C., 2019. Are innovation and new technologies in precision medicine paving a new era in patients centric care?. Journal of translational medicine, 17(1), p.114.
  49. Garrison Jr, L.P. and Towse, A., 2019. A strategy to support efficient development and use of innovations in personalized medicine and precision medicine. Journal of Managed Care & Specialty Pharmacy, 25(10), pp.1082-1087.
  50. Al-Dewik, N.I., Younes, S.N., Essa, M.M., Pathak, S. and Qoronfleh, M.W., 2022. Making biomarkers relevant to healthcare innovation and precision medicine. Processes, 10(6), p.1107.
  51. Gong, H., 2020. Innovation ecosystems for precision medicine implementation (Doctoral dissertation, University of Pennsylvania).
  52. Love-Koh, J., Peel, A., Rejon-Parrilla, J.C., Ennis, K., Lovett, R., Manca, A., Chalkidou, A., Wood, H. and Taylor, M., 2018. The future of precision medicine: potential impacts for health technology assessment. Pharmacoeconomics, 36, pp.1439-1451.
  53. Ginsburg, G.S. and Phillips, K.A., 2018. Precision medicine: from science to value. Health affairs, 37(5), pp.694-701.
  54. García-Foncillas, J., Argente, J., Bujanda, L., Cardona, V., Casanova, B., Fernández-Montes, A., Horcajadas, J.A., Iñiguez, A., Ortiz, A., Pablos, J.L. and Pérez Gómez, M.V., 2021. Milestones of precision medicine: an innovative, multidisciplinary overview. Molecular Diagnosis & Therapy, 25, pp.563-576.
  55. Liu, X., Luo, X., Jiang, C. and Zhao, H., 2019. Difficulties and challenges in the development of precision medicine. Clinical Genetics, 95(5), pp.569-574.
  56. Cazzola, M., Calzetta, L., Rogliani, P. and Matera, M.G., 2017. The challenges of precision medicine in COPD. Molecular diagnosis & therapy, 21, pp.345-355.
  57. Cerrato, P. and Halamka, J., 2017. Realizing the promise of precision medicine: the role of patient data, mobile technology, and consumer engagement. Academic Press.
  58. Fohner, A.E., Volk, K.G. and Woodahl, E.L., 2019. Democratizing precision medicine through community engagement. Clinical pharmacology and therapeutics, 106(3), p.488.
  59. Tuttle, K.R., Knight, R., Appelbaum, P.S., Arora, T., Bansal, S., Bebiak, J., Brown, K., Campbell, C., Cooperman, L., Corona-Villalobos, C.P. and Dighe, A., 2021. Integrating patient priorities with science by community engagement in the Kidney Precision Medicine Project. Clinical Journal of the American Society of Nephrology, 16(4), pp.660-668.
  60. Griffin, A.C., Topaloglu, U., Davis, S. and Chung, A.E., 2020. From patient engagement to precision oncology: leveraging informatics to advance cancer care. Yearbook of Medical Informatics, 29(01), pp.235-242.
  61. Dzau, V.J. and Ginsburg, G.S., 2016. Realizing the full potential of precision medicine in health and health care. Jama, 316(16), pp.1659-1660.
  62. Wynn, R.M., Adams, K.T., Kowalski, R.L., Shivega, W.G., Ratwani, R.M. and Miller, K.E., 2018. The patient in precision medicine: a systematic review examining evaluations of patient-facing materials. Journal of healthcare engineering, 2018.
  63. Adams, S.A. and Petersen, C., 2016. Precision medicine: opportunities, possibilities, and challenges for patients and providers. Journal of the American Medical Informatics Association, 23(4), pp.787-790.
  64. Blasimme, A. and Vayena, E., 2016. “Tailored-to-You”: Public Engagement and the Political Legitimation of Precision Medicine. Perspectives in Biology and Medicine, 59(2), pp.172-188.
  65. Frey, L.J., Bernstam, E.V. and Denny, J.C., 2016. Precision medicine informatics. Journal of the American Medical Informatics Association, 23(4), pp.668-670.
  66. Zhang, Y., Zhu, Q. and Liu, H., 2015. Next generation informatics for big data in precision medicine era. BioData Mining, 8, pp.1-3.
Regular Issue Subscription Review Article
Volume 01
Issue 02
Received March 21, 2024
Accepted March 22, 2024
Published March 30, 2024
Views: 47